Literature DB >> 15699102

B cell selection and susceptibility to autoimmunity.

Christine M Grimaldi1, Ruthmarie Hicks, Betty Diamond.   

Abstract

Autoreactive B cells arise routinely as part of the naive B cell repertoire. The immune system employs several mechanisms in an attempt to silence these autoreactive cells before they achieve immunocompetence. The BCR plays a central role in B cell development, activation, survival, and apoptosis, and thus is a critical component of the regulation of both protective and autoreactive B cells. The strength of signal mediated by the BCR is determined by numerous factors, both B cell intrinsic and B cell extrinsic. Perturbations in the molecules that regulate the BCR signal strength or that activate pathways that engage in cross talk with the BCR-mediated signaling pathways can lead to the aberrant survival and activation of autoreactive B cells. In this review, we will discuss the some newly identified genetic loci and factors that modulate the BCR signal transduction pathway and, therefore, the regulation of autoreactive B cells. We will also provide evidence for a model of autoreactivity in which a reduction in the strength of the BCR signal allows the survival and the modulation of a naive B cell repertoire replete with autoreactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699102     DOI: 10.4049/jimmunol.174.4.1775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Functional autoantibodies in systemic sclerosis.

Authors:  Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal:  Semin Immunopathol       Date:  2015-08-21       Impact factor: 9.623

Review 2.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

3.  Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.

Authors:  Anne Baerenwaldt; Anja Lux; Heike Danzer; Bernd M Spriewald; Evelyn Ullrich; Gordon Heidkamp; Diana Dudziak; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

4.  Estrogen augments the T cell-dependent but not the T-independent immune response.

Authors:  Mónika Adori; Endre Kiss; Zsuzsanna Barad; Klaudia Barabás; Edda Kiszely; Andrea Schneider; Dorottya Kövesdi; Erna Sziksz; István M Abrahám; János Matkó; Gabriella Sármay
Journal:  Cell Mol Life Sci       Date:  2010-02-07       Impact factor: 9.261

5.  Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.

Authors:  R Gill; M J McCabe; A J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-28       Impact factor: 4.219

6.  SLAP deficiency decreases dsDNA autoantibody production.

Authors:  Lisa K Peterson; Luke F Pennington; Laura A Shaw; Meredith Brown; Eric C Treacy; Samantha F Friend; Øyvind Hatlevik; Kira Rubtsova; Anatoly V Rubtsov; Leonard L Dragone
Journal:  Clin Immunol       Date:  2013-12-31       Impact factor: 3.969

7.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

8.  B cell autoimmunity at the extremes.

Authors:  Julie Zikherman; Clifford A Lowell
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

Review 9.  Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.

Authors:  Harini Bagavant; Kambiz Kalantarinia; Yogesh Scindia; Umesh Deshmukh
Journal:  Am J Kidney Dis       Date:  2011-01-15       Impact factor: 8.860

Review 10.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.